Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease

Journal of General Virology

Volumn 88, Issue 3, 2007, Pages 1068-1072

  Peden, Alexander H ^a   Ritchie, Diane L ^a   Uddin, Hafsana P ^a,c   Dean, Andrew F ^b   Schiller, Kimberly A F ^a   Head, Mark W ^a   Ironside, James W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PRION PROTEIN; PROTEINASE K;

ADENOHYPOPHYSIS; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IATROGENIC DISEASE; IMMUNOHISTOCHEMISTRY; NEUROHYPOPHYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CREUTZFELDT-JAKOB SYNDROME; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; PITUITARY GLAND, POSTERIOR; PRIONS;

EID: 33847632588     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81913-0     Document Type: Article

References (21)

1. Brown, P., Brandel, J. P., Preese, M. & Sato, T. (2006). Iatrogenic Creutzfeldt-Jakob disease: The waning of an era. Neurology 67, 389-393.
2. Budka, H., Aguzzi, A., Brown, P., Brucher, J. M., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J. J., Ironside, J. W. & other authors (1995). Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiforin encephalopathies (prion diseases). Brain Pathol 5, 459-466.
3. Cervenakova, L., Yakovleva, O. & McKenzie, C. (2006). Protease-resistant prion protein in lymphoreticular tumors of variant Creutzfeldt-Jakob disease mice. Emerg Infect Dis 12, 511-513.
4. Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. (1996). Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690.
5. Fauquier, T., Lacampagne, A., Travo, P., Bauer, K. & Mollard, P. (2002). Hidden face of the anterior pituitary. Trends Endocrinol Metab 13, 304-309.
6. Gambetti, P., Kong, O., Zou, W., Parchi, P. & Chen, S. G. (2003). Sporadic and familial CJD: Classification and characterisation. Br Med Bull 66, 213-239.
7. Gayrard, V., Picard-Hagen, N., Grino, M., Sauze, N., Grandjean, C., Galea, J., Andreoletti, O., Schelcher, F. & Toutain, P. L. (2000). Major hypercorticism is an endocrine feature of ewes with naturally occurring scrapie. Endocrinology 141, 988-994.
8. Gibbs, C. J., Jr, Asher, D. M., Brown, P. W., Fradkin, J. E & Gajdusek, D. C. (1993). Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. N Engl J Med 328, 358-359.
9. Glatzel, M., Abela, E, Meissen, M. & Aguzzi, A. (2003). Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349, 1812-1820.
10. Head, M. W., Northcott, V., Rennison, K, Ritchie, D., McCardle, L., Bunn, T. J., McLennan, N. F., Ironside, J. W., Tullo, A. B. & Bonshek, R. E. (2003). Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease. Invest Ophthalmol Vis Sci 44, 342-346.
11. Head, M. W., Bunn, T. J., Bishop, M. T., McLoughlin, V., Lowrie, S., McKimmie, C. S., Williams, M. C., McCardle, L, MacKenzie, J. & other authors (2004a). Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 55, 851-859.
12. Head, M. W., Ritchie, D., Smith, N., McLoughlin, V., Nailon, W., Samad, S., Masson, S., Bishop, M., McCardle, L & Ironside, J. W. (2004b). Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 164, 143-153.
13. Head, M. W., Peden, A. H., Yull, H. M., Ritchie, D. L, Bonshek, R. E, Tullo, A. B. & Ironside, J. W. (2005). Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-jakob disease. Br J Ophthalmol 89, 1131-1133.
14. Hilton, D. A., Ghani, A. C., Conyers, L., Edwards, P., McCardle, L., Ritchie, D., Penney, M., Hegazy, D. & Ironside, J. W. (2004). Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203, 733-739.
15. Ironside, J. W., Head, M. W., Bell, J. E., McCardle, L. & Will, R. G. (2000). Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37, 1-9.
16. Ladogana, A., Puopolo, M., Croes, E. A., Budka, H., Jarius, C., Collins, S., Klug, G. M., Sutcliffe, T., Giulivi, A. & other authors (2005). Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64, 1586-1591.
17. Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K, Chen, S. G., Farlow, M., Dickson, D. W., Sima, A. A. & other authors (1996). Molecular basis of phenotypic variability in sporadic Creutzfeldt-jakob disease. Ann Neurol 39, 767-778.
18. Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. (2004). Preclinical. vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529.
19. Sabattini, E, Bisgaard, K., Ascani, S., Poggi, S., Piccioli, M., Ceccarelli, C., Pied, F., Fraternali-Orcioni, G. & Piled, S. A. (1998). The EnVision + + system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51, 506-511.
20. Wadsworth, J. D., Joiner, S., Hill, A. F., Campbell, T. A., Desbruslais, M., Luthert, P. J. & Collinge, J. (2001). Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180.
21. Will, R. G. (2003). Acquired prion disease: Iatrogenic CJD, variant CJD, kuru. Br Med Bull 66, 255-265.